SLS vs WYNN · $1.62B cap vs P/E 29, rev $3.71B
Sellas Life Sciences Group Inc (SLS) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
Latest reported WYNN revenue for 2026-06-30 was $3.71B. Net income was $260.5M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
SLS currently screens at market cap $1.62B. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the SLS and WYNN stock pages for the full models.
Not investment advice.